key: cord-0967076-2ltldr9j
authors: Gao, Shan; Lu, Yue; Luan, Junwen; Zhang, Leiliang
title: Low incidence rate of diarrhoea in COVID-19 patients is due to integrin
date: 2021-07-15
journal: J Infect
DOI: 10.1016/j.jinf.2021.07.007
sha: d3635a542be6c0e1696f95a3fc7214428958defb
doc_id: 967076
cord_uid: 2ltldr9j

nan

Coronavirus disease-19 (COVID-19), which was caused by Severe Acute Respiratory Syndrome-related Coronavirus 2 (SARS-CoV-2), has been a global pandemic. The first key step of SARS-CoV-2 entry is attachment and binding to cell receptor angiotensin-converting enzyme 2 (ACE2) by spike protein (S) (1) . Integrin family consists of 18 α and 8 β subunits, which form tens of transmembrane heterodimers. It has been determined that many integrins associated with other proteins by recognizing RGD or KGD peptide. Previous we proposed an inhibitory role for integrin in the receptor targeting of SARS-CoV-2 (2) . Both S protein of SARS-CoV-2 and ACE2

have an RGD in their sequences, with ACE2 possessing a KGD (2) . Based on the integrin-binding motif in S sequence, other researchers hypothesized that integrin could be an alternative receptor for SARS-CoV-2(3). However, the real function of integrin in SARS-CoV-2 entry is not determined experimentally.

To verify the interaction of integrin with SARS-CoV-2 S and ACE2, we over-expressed these proteins in 293T cells and performed co-immunoprecipitation (co-IP). Integrin β5 was found to interact with S and ACE2 ( Figure 1A ). The association of integrin αV with S and ACE2 was also confirmed ( Figure S1 ). These results indicated that integrin can interact with the S protein of SARS-CoV-2 and ACE2 respectively. Because RGD/KGD residues are classical integrin binding motifs, we went on to determine the dependence of these motifs in S-integrin and ACE2-integrin interactions. We constructed RGE and RGA mutants of S. Co-IP showed that either RGE or RGA bound with integrin β5 less ( Figure 1B) , suggesting that RGD motif was important for integrin binding. S 405E mutation significantly suppressed integrin αV binding ( Figure 1B ). The KGD motif in ACE2 was mutated to KGE and KGA. The amount of mutant ACE2 co-immunoprecipitated with integrin αV and β5 was lower than wild type ACE2 ( Figure S2 ), indicating that KGD residues was involved in ACE2-integrin αV interaction.

Having confirmed the interaction of integrin with S and ACE2, we proposed that integrin potentially interrupted receptor targeting of SARS-CoV-2 S. To test our hypothesis, we transfected plasmids expressing ACE2 and S into 293T cells in the presence or absence of integrin. GFP-tagged S co-precipitated less ACE2 in the presence of integrin αV ( Figure 1C ). Co-IP using S, ACE2 and integrin β5 came to the same result ( Figure 1C ). These results demonstrated that integrin could interfere with the binding of ACE2 and SARS-CoV-2 S protein.

The inhibitory role of integrin in S-ACE2 binding suggested that the integrin could perturb the entry of SARS-CoV-2. Taking advantage of pseudovirus system which has been successfully established in our lab, we went further to determine the role of integrin in SARS-CoV-2 entry. This SARS-CoV-2 pseudovirus particle (SARS-CoV-2pp) was packaged by four plasmids expressing firefly luciferase, gag, rev, S protein respectively. The S is changed to envelope G protein of vesicular stomatitis virus (VSV) for constructing VSVpp. We first tested whether integrin itself supported SARS-CoV-2 entry by transfecting 293T cells with integrin αV only. In contrast to 293T cells transfected with human ACE2, 293T cells expressing integrin αV produced undetectable luciferase activity signal ( Figure S3 ). This result indicated that integrin was not a receptor for SARS-CoV-2 pseudovirus. Then we examined the effect of exogeneous integrin on SARS-CoV-2 entry into 293T cells expressing ACE2.

Compared to unconditioned group, pretreatment of either SARS-CoV-2pp or cells with exogenous integrin αVβ5 reduced luciferase activity ( Figure 1D ). However, incubating VSVpp with integrin αVβ5 did not affect VSVpp entry ( Figure 1D ).

Pretreating 293T cells slightly inhibited VSVpp entry. Integrin αVβ5 addition did not change cell viability in all these conditions ( Figure 1D ).

However, the incidence rate of diarrhoea in COVID-19 patients is low (8) . We In conclusion, our work found that both αV and β5 subtype of integrin inhibited S-ACE2 interaction and entry of SARS-CoV-2pp by binding to S and ACE2, which largely relied on RGD/KGD motifs. ACE2 has been proven to mediate SARS-CoV-2 entry into human cells by researches on multiple levels. ACE2 is found highly 

The authors declare that there are no conflicts of interest. Figure 1 Integrin inhibited SARS-CoV-2 pseudovirus infection through inhibition of S-ACE2 binding. (A) Integrin β5 interacted with SARS-CoV-2 S and ACE2. Left, Myc-tagged integrin β5 with or without GFP-tagged S was transfected into 293T cells. Cell lysates were immunoprecipitated using anti-GFP antibody. Right, integrin β5-Myc was expressed in 293T cells with or without ACE2-HA. Cell lysates were precipitated with anti-HA antibody. (B) RGD motif in S protein was important for its binding with integrin β5 and integrin αV. Left, Wild type S and two single-amino acid mutants (405E, 405A) were expressed in 293T cells receptively with integrin β5-Myc. Right, wild type S or S 405E mutant was expressed in 293T cells. Lysates was immunoprecipitated by GFP. (C) SARS-CoV-2 S and ACE2 interaction was inhibited by integrin αV and integrin β5. GFP-tagged full-length S and HA-tagged ACE2 were co-expressed in 293T cells with or without Myc-tagged integrin αV. Right, GFP-S and ACE2-HA were transfected with or without integrin β5-Myc. and B8(ITGB8) in 14 cell populations were presented by violin plots. 0, small intestine enterocyte progenitor cell; 1, large intestine paneth-like cell; 2, small intestine enterocyte; 3, large intestine stem cell; 4, small intestine stem cell; 5, small intestine paneth cell; 6, large intestine enterocyte; 7, small intestine transit amplifying cell; 8, large intestine goblet cell; 9, small intestine goblet cell; 10, large intestine enterocyte progenitor cell; 11, large intestine enteroendocrine cell; 12, large intestine transit amplifying cell; 13, small intestine enteroendocrine cell.

A pneumonia outbreak associated with a new coronavirus of probable bat origin

A potential inhibitory role for integrin in the receptor targeting of SARS-CoV-2

A potential role for integrins in host cell entry by SARS-CoV-2

Epidemiological, clinical and virological characteristics of 74 cases of coronavirus

Diarrhoea may be underestimated: a missing link in 2019 novel coronavirus

Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection

SARS-CoV-2 induced diarrhoea as onset symptom in patient with COVID-19

Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis

This work was supported by grants from National Natural Science Foundation of